which produce dopamine. Although in rare cases there may be genetic and environmental factors, the precise cause leading to the disease remains unknown. The condition often remains undiagnosed in the initial stages, as its onset is so slow. Even when suspected, there is no simple test to immediately confirm a diagnosis. A careful history, as well as thorough physical and neurological examinations, should create a high degree of suspicion leading to referral to a neurologist as soon as possible. Blood tests, MRI and Pet scans are often ordered, mainly to rule out other conditions. For cases in which there is a family history, genetic testing may be indicated. In the end, careful assessment by a neurologist will lead to the diagnosis. Once the diagnosis has been made, treatment initiatives should begin. If the patient is hospitalized, outpatient occupational therapy and physiotherapy will be initiated. Medications may be ordered, which could alleviate symptoms to some extent and, hopefully, slow the progression of the condition. After treatment commences, improvement in symptoms further supports the diagnosis. Many patients experience improvement and may live independently for many years, receiving their medication, ongoing physical and occupational support and regular neurological followup. For advanced cases, institutional care may eventually be necessary to provide more intensive management. The medication to help control the symptoms of Parkinson’s disease is Levodopa. The drug is converted in the brain to dopamine, the natural chemical that is deficient in patients with the condition. This results in improvement in motor control. Levodopa is often combined with another drug to lessen side-effects. This combination drug, the most common medication prescribed for Parkinson’s disease, is Sinemet. Other medications may be prescribed according to the patient’s particular symptoms. A major support group – Parkinson Canada (www.parkinson.ca) – offers information and support for persons affected and their families, as well as supporting research into the cause and management of the condition. The Michael J. Fox Foundation (www.michaeljfox.org) is dedicated both to finding a cure for Parkinson’s disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with the condition. Research into Parkinson’s disease continues throughout the world, with some recent results giving further hope that some day, the condition can be cured or prevented. Health CSANews | SPRING 2026 | 35
RkJQdWJsaXNoZXIy MzMzNzMx